- Home
- IDR vs CYRX Comparison
IDR vs CYRX Comparison
Compare IDR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDR
- CYRX
- Stock Information
- Founded
- IDR 1996
- CYRX 1999
- Country
- IDR United States
- CYRX United States
- Employees
- IDR N/A
- CYRX N/A
- Industry
- IDR Precious Metals
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- IDR Basic Materials
- CYRX Health Care
- Exchange
- IDR Nasdaq
- CYRX Nasdaq
- Market Cap
- IDR 378.0M
- CYRX 438.7M
- IPO Year
- IDR N/A
- CYRX N/A
- Fundamental
- Price
- IDR $34.85
- CYRX $8.73
- Analyst Decision
- IDR Strong Buy
- CYRX Strong Buy
- Analyst Count
- IDR 1
- CYRX 9
- Target Price
- IDR $17.50
- CYRX $12.83
- AVG Volume (30 Days)
- IDR 589.8K
- CYRX 708.3K
- Earning Date
- IDR 11-12-2025
- CYRX 11-04-2025
- Dividend Yield
- IDR N/A
- CYRX N/A
- EPS Growth
- IDR 52.70
- CYRX N/A
- EPS
- IDR 0.73
- CYRX 1.27
- Revenue
- IDR $35,424,313.00
- CYRX $243,795,000.00
- Revenue This Year
- IDR $21.91
- CYRX N/A
- Revenue Next Year
- IDR $5.47
- CYRX $9.20
- P/E Ratio
- IDR $48.40
- CYRX $6.86
- Revenue Growth
- IDR 61.35
- CYRX 41.27
- 52 Week Low
- IDR $9.67
- CYRX $4.58
- 52 Week High
- IDR $54.70
- CYRX $11.44
- Technical
- Relative Strength Index (RSI)
- IDR 52.29
- CYRX 43.47
- Support Level
- IDR $31.06
- CYRX $8.14
- Resistance Level
- IDR $33.88
- CYRX $9.29
- Average True Range (ATR)
- IDR 3.25
- CYRX 0.60
- MACD
- IDR 0.12
- CYRX -0.06
- Stochastic Oscillator
- IDR 94.32
- CYRX 23.00
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.